FormFactor (FORM) Updated Its Outlook, Is The Valuation Still Too Rich?

FormFactor (FORM) is back in focus after reporting second quarter results and updating its near term outlook, giving investors fresh data on sales, profitability, and expectations for the coming quarter.

See our latest analysis for FormFactor.

Despite FormFactor’s solid earnings update and new partnership announcements, the share price has fallen 26.4% over the past week and 42.1% over the past month. However, year to date the share price return is up 41% and the 1 year total shareholder return is 142.5%, so momentum has recently cooled after a strong run.

If FormFactor’s recent moves have you reassessing semiconductor exposure, this could be a good time to scan the wider chip space using our screener for 56 AI infrastructure stocks

Bulls point to FormFactor’s profit jump and Taiwan partnership, while bears focus on the sharp pullback in the share price. Which side does the current valuation evidence support next?

Advertisement

Most Popular Narrative: 42.3% Undervalued

FormFactor's most followed narrative pegs fair value at $144.67 per share compared with the last close of $83.45, which frames a wide valuation gap that hinges on AI driven chip testing demand and execution at new manufacturing sites.

Accelerating adoption of generative AI, high-performance computing, and HBM DRAM in data centers is driving substantial increases in test complexity and intensity. FormFactor's differentiated probe cards and early leadership in HBM4 chiplet testing position the company to benefit from higher ASPs and revenue growth as these markets scale. (Impacts: Revenue, potential margin improvement)

Read the complete narrative.

Curious what earnings path and margin profile sit behind that fair value and discount rate assumption. The narrative leans heavily on compound revenue growth, rising profitability and a slimmer valuation multiple than many headline AI hardware stocks.

Result: Fair Value of $144.67 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, FormFactor’s story is not risk free, with margin pressure from product mix and higher operating costs, as well as exposure to U.S. and China trade policy changes.

Find out about the key risks to this FormFactor narrative.

Another View on FormFactor’s Valuation

The analyst narrative leans on a fair value of $144.67 per share, yet FormFactor currently trades on a P/E of 95.2x. That is far above the US Semiconductor industry on 47.3x, its peer average of 73.1x, and even a fair ratio of 77.4x, which suggests meaningful valuation risk if expectations slip. How comfortable are you paying that kind of premium for this growth story?

For a closer look at how these valuation gaps stack up using earnings multiples, and what they could mean if the market moves toward the fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:FORM P/E Ratio as at Jul 2026
NasdaqGS:FORM P/E Ratio as at Jul 2026

Next Steps

With FormFactor pulling strong opinions on both sides, it makes sense to check the underlying data and move quickly to form your own stance using the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond FormFactor?

Do not stop with FormFactor. Broaden your watchlist now using targeted stock ideas so you are not relying on a single story for future returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:FORM

FormFactor

Designs, manufactures, and sells probe cards, analytical probes, probe stations, thermal systems, cryogenic systems, and related services in the United States, South Korea, Taiwan, China, Japan, Singapore, Europe, Malaysia, and internationally.

Flawless balance sheet with reasonable growth potential.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2554.7% undervalued
110 users have followed this narrative
0 users have commented on this narrative
24 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4859.0% undervalued
213 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43047.7% undervalued
20 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9953.6% undervalued
26 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

TH
TheGrayWolf_80
SCHD logo
TheGrayWolf_80 on Schwab Strategic Trust - Schwab U.S. Dividend Equity ETF ·

Building a 75/15/10 Income Machine with Schwab's Dividend ETF

Fair Value:US$63.7546.9% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SI
MSFT logo
simplydunno on Microsoft ·

Microsoft's Capex Bill Comes Due Before the AI Revenue Does

Fair Value:US$512.123.7% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
NGXGROUP logo
Henrynuke03 on Nigerian Exchange Group ·

Future Growth Awaits NGXGROUP with New High-Profile Listings

Fair Value:₦221.1732.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28032.1% undervalued
211 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.0% undervalued
97 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.2% undervalued
74 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0